Serum type xix collagen is significantly elevated in non-small cell lung cancer: A preliminary study on biomarker potential
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- OA-Serum Type XIX Collagen is Significantly
Final published version, 1.2 MB, PDF document
Type XIX collagen is a poorly characterized collagen associated with the basement membrane. It is abnormally regulated during breast cancer progression and the NC1 (XIX) domain has anti-tumorigenic signaling properties. However, little is known about the biomarker potential of collagen XIX in cancer. In this study, we describe a competitive ELISA, named PRO-C19, targeting the C-terminus of collagen XIX using a monoclonal antibody. PRO-C19 was measured in serum of patients with a range of cancer types and was elevated in non-small cell lung cancer (NSCLC) (p < 0.0001), small cell lung cancer (p = 0.0081), breast (p = 0.0005) and ovarian cancer (p < 0.0001) compared to healthy controls. In a separate NSCLC cohort, PRO-C19 was elevated compared to controls when evaluating adenocarcinoma (AD) (p = 0.0003) and squamous cell carcinoma (SCC) (p < 0.0001) patients but was not elevated in chronic obstructive pulmonary disease patients. SCC also had higher PRO-C19 levels than AD (p = 0.0457). PRO-C19 could discriminate between NSCLC and healthy controls (AUROC:0.749 and 0.826 for AD and SCC, respectively) and maintained discriminatory performance in patients of tumor stages I+II (AUROC:0.733 and 0.818 for AD and SCC, respectively). Lastly, we confirmed the elevated type XIX collagen levels using gene expression data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) initiatives. In conclusion, type XIX collagen is released into circulation and is significantly elevated in the serum of cancer patients and PRO-C19 shows promise as a cancer biomarker.
Original language | English |
---|---|
Article number | 1510 |
Journal | Cancers |
Volume | 12 |
Issue number | 6 |
Pages (from-to) | 1-14 |
ISSN | 2072-6694 |
DOIs | |
Publication status | Published - 2020 |
- AD, Biomarker, Cancer, Collagen XIX, ECM, NSCLC, SCC, Serum
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 246826454